Glucotrol, Glipizide News

Takeda Pharmaceutical Company Limited announced today that it has reviewed the development strategy for the Marketing Authorization Applications for its investigational compounds, alogliptin and alogliptin/ACTOS , in Europe, and accordingly, has initiated an additional long-term clinical study for alogliptin.

PPD, Inc. today confirmed that Takeda Pharmaceutical Company Limited has notified the European Medicines Agency, or EMEA, that it will postpone its marketing authorization applications for alogliptin and alogliptin/ACTOS , originally planned for mid-2009, because it is initiating a long-term clinical trial for alogliptin.

A class of diabetes drugs sometimes called “starch blockers” that blocks the action of enzymes that normally begin to break down certain carbohydrates in the upper part of the small intestine.

Typical monthly costs for medicines and testing supplies to control diabetes, for two common categories of patients who don't have other health problems.

Both intensive oral combination therapy and antecedent hypoglycemia blunt the body's physiological defenses against later hypoglycemia in people with type 2 diabetes, according to a recent study by researchers at Vanderbilt University, Nashville, published in the March issue of the journal Diabetes.

Diabetes is the sixth leading cause of death both nationally and in Utah. On Tuesday, Diabetes experts from the Utah State Department of Health are here to answer your questions.

Pfizer Inc., the world's largest pharmaceutical company, has announced an agreement to buy one of its rivals, Wyeth, for $68 billion, the Wall Street Journal reports.

When most people find out they have Type 2 diabetes , they are first instructed to make changes in their diet and lifestyle.

Published: Thursday, January 8, 2009 at 1:00 a.m. Last Modified: Tuesday, January 6, 2009 at 5:50 p.m. Dear Dr.